article thumbnail

Tome Biosciences debuts with $213M and a new way to edit the genome

Bio Pharma Dive

Based on the work of MIT scientists, the well-funded startup is developing ways to insert large sizes of genetic material anywhere in the genome without damaging or breaking DNA.

Genomics 330
article thumbnail

EU pharma trade body starts genomic profiling initiative to improve access

Pharmaceutical Technology

The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) and selected pharma and medical device companies have launched the European Coalition for Access to Comprehensive Genomic Profiling (ECGP), to promote the routine use of comprehensive genomic profiling.

Genomics 264
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Genomic Medicine Revolution: Multi-Modality Approaches in Advanced Therapies 

Pharmaceutical Technology

Genomic medicines offer new techniques for treating conditions once thought to be intractable - a world of opportunity awaits.

Genomics 246
article thumbnail

AstraZeneca, seeking new drug targets, taps a genomics biotech and its AI technology

Bio Pharma Dive

Worth up to $840 million, the collaboration will give Alexion access to Verge Genomics’ platform, which uses human tissue data to find drug targets for diseases that degrade the nerve system.

Genomics 290
article thumbnail

Analyze whole genome sequencing samples at the speed of light

Bio Pharma Dive

Deliver fast and reliable results at low cost with a tool for whole genome analysis in just minutes

Genomics 246
article thumbnail

Tome acquires startup Replace, gaining new genome editing tools

Bio Pharma Dive

The deal is the second startup sale engineered by University of California, Berkeley scientist Shakked Halperin, and gives Tome a way to insert or delete small DNA sequences into the genome.

Genomics 173
article thumbnail

Modernizing cell culture processes for the next wave of genomic medicine

Pharmaceutical Technology

The field of genomic medicine has reached a true turning point. More efficient, suspension-based cell culture processes are urgently needed in the now fast-developing genomic medicine space. © 2022 Cytiva The post Modernizing cell culture processes for the next wave of genomic medicine appeared first on Pharmaceutical Technology.

Genomics 244